Mohammed A R, Weston N, Coombes A G A, Fitzgerald M, Perrie Y
Medicines Research Institute, Aston Pharmacy School, Aston University, Aston Triangle, Birmingham B4 7ET, UK.
Int J Pharm. 2004 Nov 5;285(1-2):23-34. doi: 10.1016/j.ijpharm.2004.07.010.
Liposomes due to their biphasic characteristic and diversity in design, composition and construction, offer a dynamic and adaptable technology for enhancing drug solubility. Starting with equimolar egg-phosphatidylcholine (PC)/cholesterol liposomes, the influence of the liposomal composition and surface charge on the incorporation and retention of a model poorly water soluble drug, ibuprofen was investigated. Both the incorporation and the release of ibuprofen were influenced by the lipid composition of the multi-lamellar vesicles (MLV) with inclusion of the long alkyl chain lipid (dilignoceroyl phosphatidylcholine (C24PC)) resulting in enhanced ibuprofen incorporation efficiency and retention. The cholesterol content of the liposome bilayer was also shown to influence ibuprofen incorporation with maximum ibuprofen incorporation efficiency achieved when 4 micromol of cholesterol was present in the MLV formulation. Addition of anionic lipid dicetylphosphate (DCP) reduced ibuprofen drug loading presumably due to electrostatic repulsive forces between the carboxyl group of ibuprofen and the anionic head-group of DCP. In contrast, the addition of 2 micromol of the cationic lipid stearylamine (SA) to the liposome formulation (PC:Chol - 16 micromol:4 micromol) increased ibuprofen incorporation efficiency by approximately 8%. However further increases of the SA content to 4 micromol and above reduced incorporation by almost 50% compared to liposome formulations excluding the cationic lipid. Environmental scanning electron microscopy (ESEM) was used to dynamically follow the changes in liposome morphology during dehydration to provide an alternative assay of liposome stability. ESEM analysis clearly demonstrated that ibuprofen incorporation improved the stability of PC:Chol liposomes as evidenced by an increased resistance to coalescence during dehydration. These finding suggest a positive interaction between amphiphilic ibuprofen molecules and the bilayer structure of the liposome.
脂质体因其双相特性以及在设计、组成和结构方面的多样性,为提高药物溶解度提供了一种动态且适应性强的技术。从等摩尔的蛋黄卵磷脂(PC)/胆固醇脂质体开始,研究了脂质体组成和表面电荷对一种难溶性模型药物布洛芬包封率和保留率的影响。多层囊泡(MLV)的脂质组成会影响布洛芬的包封和释放,包含长烷基链脂质(二神经酰胺磷脂酰胆碱(C24PC))会提高布洛芬的包封效率和保留率。脂质体双层中的胆固醇含量也显示出会影响布洛芬的包封,当MLV制剂中存在4微摩尔胆固醇时,可实现最大的布洛芬包封效率。添加阴离子脂质二鲸蜡基磷酸酯(DCP)会降低布洛芬的载药量,这可能是由于布洛芬的羧基与DCP的阴离子头基之间存在静电排斥力。相反,向脂质体制剂(PC:胆固醇 - 16微摩尔:4微摩尔)中添加2微摩尔阳离子脂质硬脂胺(SA)可使布洛芬的包封效率提高约8%。然而,与不含阳离子脂质的脂质体制剂相比,将SA含量进一步提高到4微摩尔及以上会使包封率降低近50%。环境扫描电子显微镜(ESEM)用于动态跟踪脱水过程中脂质体形态的变化,以提供脂质体稳定性的另一种检测方法。ESEM分析清楚地表明,布洛芬的包封提高了PC:胆固醇脂质体的稳定性,脱水过程中抗聚结能力增强证明了这一点。这些发现表明两亲性布洛芬分子与脂质体的双层结构之间存在积极的相互作用。